Isolation of an amikacin-resistant Escherichia coli strain after tobramycin treatment of previous recurrent episodes of respiratory tract infections caused by Pseudomonas aeruginosa
- ,
- S. Bertran,
- G. Sauca,
- A. Julià,
- X. Vila,
- E. Gómez
- ,
- Hospital Clinic Barcelona,
- Hospital de Mataró
Research Output:
Contribution to journal
Article
Peer-review
Open access
Publication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 71-73 (3 pages)Journal (Volume, Issue Number)
Clinical Microbiology and Infection (Volume 11, Issue 1)Publication milestones
- Published - 01/2005
Publication status
Published - 01/2005
ISSN
1198-743XPublication IDs
- Scopus: 13644253406
- PubMed: 15649309
Abstract
Amikacin-resistant Escherichia coli strains are isolated rarely from clinical samples. In the present study, investigation of an amikacin-resistant clinical isolate of E. coli demonstrated the presence of two class 1 integrons carrying the aacA4 gene plus the aacA7 gene, and the dfrA17 gene plus the aadA5 gene, respectively. Resistance to amikacin in the E. coli isolate was related to the presence of both aacA4 and aacA7.
Funding Details
This study was supported by grant 02/0353 from the Fondo de Investigaciones Sanitarias of Spain, and grant 2002SGR00121 from the Departament d'Universitats, Recerca I Societat de la Informació, Generalitat de Catalunya, Spain.
FundersFunding numbers
Generalitat de Catalunya
-DURSI
-Publication metrics
Metrics
PlumX, opens in new tab
Citations
4
Captures
27
Sustainable Development Goals
SDG 3 Good Health and Well